Detalhe da pesquisa
1.
Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study.
Vaccine
; 41(10): 1657-1667, 2023 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36746739
2.
Value profile for respiratory syncytial virus vaccines and monoclonal antibodies.
Vaccine
; 41 Suppl 2: S7-S40, 2023 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37422378
3.
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape.
Lancet Infect Dis
; 23(1): e2-e21, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35952703
4.
Impact and cost-effectiveness of potential interventions against infant respiratory syncytial virus (RSV) in 131 low-income and middle-income countries using a static cohort model.
BMJ Open
; 11(4): e046563, 2021 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33895717
5.
RSV neutralization assays - Use in immune response assessment.
Vaccine
; 39(33): 4591-4597, 2021 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34244007
6.
Inferring antenatal care visit timing in low- and middle-income countries: Methods to inform potential maternal vaccine coverage.
PLoS One
; 15(8): e0237718, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32817688
7.
Tracking progress in universal influenza vaccine development.
Curr Opin Virol
; 40: 28-36, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32279026
8.
Lessons learned from the Advancing Maternal Immunization collaboration: identifying evidence gaps for informed respiratory syncytial virus maternal immunization decision-making.
Gates Open Res
; 3: 1544, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-32025632
9.
The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates.
Lancet Infect Dis
; 18(10): e295-e311, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29914800
10.
A multi-laboratory study of diverse RSV neutralization assays indicates feasibility for harmonization with an international standard.
Vaccine
; 35(23): 3082-3088, 2017 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28476625
11.
Advances in RSV vaccine research and development - A global agenda.
Vaccine
; 34(26): 2870-2875, 2016 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27105562
12.
The inability of tegaserod to affect platelet aggregation and coronary artery tone at supratherapeutic concentrations.
Naunyn Schmiedebergs Arch Pharmacol
; 385(1): 103-9, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21901313
13.
Modulation of immunogenicity and allergenicity by controlling the number of immunostimulatory oligonucleotides linked to Amb a 1.
J Allergy Clin Immunol
; 118(2): 504-10, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16890778
14.
Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus.
Antimicrob Agents Chemother
; 49(3): 1127-34, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15728913
15.
In vitro activity of TD-6424 against Staphylococcus aureus.
Antimicrob Agents Chemother
; 47(11): 3602-4, 2003 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-14576125
16.
Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimers.
J Am Chem Soc
; 125(21): 6517-31, 2003 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-12785792